Lessons learned from an unsuccessful decentralized clinical trial in Oncology

IF 12.4 1区医学 Q1 HEALTH CARE SCIENCES & SERVICES

NPJ Digital Medicine Pub Date : 2024-08-13 DOI:10.1038/s41746-024-01214-5

Antonis Valachis, Henrik Lindman

引用次数: 0

Abstract

Decentralized clinical trials have gained in popularity over the last years due to their advantages related to broadening recruitment strategies and resource saving possibilities. As more clinical trials adopt decentralized strategies, it is essential to share the knowledge about both successful and unsuccessful efforts in the research community. In the present commentary, we explore potential reasons that led to early termination of a decentralized clinical trial in Oncology.

查看原文本刊更多论文

肿瘤学分散临床试验失败的教训。

过去几年中，分散型临床试验因其在扩大招募策略和节省资源方面的优势而越来越受欢迎。随着越来越多的临床试验采用分散策略，有必要在研究界分享成功和失败的经验。在本评论中，我们探讨了导致肿瘤学分散临床试验提前终止的潜在原因。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NPJ Digital Medicine Multiple-

CiteScore

25.10

自引率

3.30%

发文量

170

审稿时长

15 weeks

期刊介绍： npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics. The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.

文献相关原料

公司名称	产品信息	采购帮参考价格